4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 112 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 172,722 | $2,198,751 | 0.00% |
| Invesco Ltd. | 17,476 | $222,469 | 0.00% |
| AMALGAMATED BANK | 3,904 | $50 | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 6,766 | $86,131 | 0.00% |
| JANE STREET GROUP, LLC | 46,924 | $597,343 | 0.00% |
| Nuveen Asset Management, LLC | 107,367 | $1,366,782 | 0.00% |
| Bank of New York Mellon Corp | 135,711 | $1,727,601 | 0.00% |
| Citadel Advisors | 4,800 | $61,104 | 0.00% |
| Citadel Advisors | 5,400 | $68,742 | 0.00% |
| Citadel Advisors | 143,220 | $1,823,191 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 18,100 | $230,413 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 16,700 | $212,591 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 20,340 | $258,928 | 0.00% |
| Swiss National Bank | 46,100 | $586,853 | 0.00% |
| Mitsubishi UFJ Asset Management Co., Ltd. | 15,278 | $194,489 | 0.00% |
| Daiwa Securities Group Inc. | 4,762 | $61 | 0.00% |
| ROYAL BANK OF CANADA | 6,485 | $83,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,575 | $20,050 | 0.00% |
| FMR LLC | 2,756 | $35,084 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 11,041 | $140,552 | 0.00% |
External links
This page lists 4D MOLECULAR THERAPEUTICS IN's shareholders in Q3 2023. To view 4D MOLECULAR THERAPEUTICS IN's shareholder history, click here.